Active ingredientSalcaprozate SodiumCat. No. P-S006-001CAS 203787-91-1Family · Pharmaceutical analytical standards
Salcaprozate
Salcaprozate sodium (SNAC) is an absorption enhancer derived from salicylic acid that helps peptides cross the stomach wall: thanks to it, semaglutide tablets were approved in the United States in 2019. This family brings together the active ingredient and other impurities.
Did you know?Around the tablet it locally raises the pH, so stomach pepsin is not activated and does not break down the drug; the first product to use it was an oral vitamin B12, in 2015.
Go to the active ingredient →Active ingredientSalcaprozate SodiumCat. No. P-S006-001CAS 203787-91-1
Impurity2-(6-Bromohexyl)propanedioic acidCat. No. P-S006-002CAS 628280-73-9
Impurity2H-1,3-Benzoxazine-2,4(3H)-dioneCat. No. P-S006-003CAS 2037-95-8
ImpuritySalcaprozate Impurity 1Cat. No. P-S006-004CAS 1100921-03-6
ImpurityDiethyl suberateCat. No. P-S006-005CAS 2050-23-9
ImpuritySalcaprozate Impurity 2Cat. No. P-S006-006CAS 287935-37-9
ImpurityEthyl 8-(2-Hydroxybenzamido)octanoateCat. No. P-S006-007CAS 1027911-46-1
ImpuritySalcaprozate Impurity 3Cat. No. P-S006-008CAS 20073-95-4
ImpurityN-(6-Bromohexyl)-2-hydroxybenzamideCat. No. P-S006-009CAS 1959004-07-9
ImpuritySalcaprozate Impurity 4Cat. No. P-S006-010CAS 65127-44-8
ImpuritySalcaprozate Impurity 5Cat. No. P-S006-011
ImpuritySalcaprozate Impurity 6Cat. No. P-S006-012CAS 1452863-52-3
ImpuritySalcaprozate Impurity 7Cat. No. P-S006-013
Active ingredientSalcaprozic AcidCat. No. P-S006-014CAS 183990-46-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.